Also, on this topic, another retrospective analysis conducted at a single institution analyzed 24 patients with BRAF-mutant MM treated with a BRAF/MEKi, which interrupted treatment due to cumulative toxicity after achieving CR or long-lasting PR (>12 months) [118]. Here, BRAF is linked to Miyoshi myopathy.